Financial results - STEREOPSIS CLINIC SRL

Financial Summary - Stereopsis Clinic Srl
Unique identification code: 15965530
Registration number: J22/2256/2003
Nace: 8622
Sales - Ron
57.050
Net Profit - Ron
19.235
Employee
2
The most important financial indicators for the company Stereopsis Clinic Srl - Unique Identification Number 15965530: sales in 2023 was 57.050 euro, registering a net profit of 19.235 euro and having an average number of 2 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Stereopsis Clinic Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 10.386 10.945 11.568 14.393 26.442 38.437 36.603 52.515 53.959 57.050
Total Income - EUR 10.408 10.945 11.568 14.393 26.442 38.437 38.654 52.515 53.959 57.050
Total Expenses - EUR 8.736 6.439 8.007 7.775 16.917 25.781 26.711 33.615 34.384 37.264
Gross Profit/Loss - EUR 1.672 4.507 3.562 6.618 9.525 12.656 11.944 18.899 19.575 19.786
Net Profit/Loss - EUR 1.433 4.172 3.236 6.163 9.265 12.255 11.587 18.374 19.036 19.235
Employees 2 1 1 1 3 3 3 3 2 2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 6.1%, from 53.959 euro in the year 2022, to 57.050 euro in 2023. The Net Profit increased by 257 euro, from 19.036 euro in 2022, to 19.235 in the last year.

Check the financial reports for the company - Stereopsis Clinic Srl

Rating financiar

Financial Rating -
Stereopsis Clinic Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Stereopsis Clinic Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Stereopsis Clinic Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Stereopsis Clinic Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Stereopsis Clinic Srl - CUI 15965530

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 0 493 488 0 32 0 0 0 54 53
Current Assets 28.630 27.802 25.387 30.336 40.023 53.205 64.126 80.800 99.235 118.463
Inventories 398 682 675 329 323 543 673 658 676 674
Receivables 27.844 26.617 23.509 23.202 23.542 23.359 63.288 79.932 98.021 116.646
Cash 388 503 1.204 6.804 16.157 29.303 166 210 538 1.143
Shareholders Funds 17.931 22.252 25.261 30.997 39.693 51.178 61.795 78.799 98.079 117.016
Social Capital 67 67 67 66 64 63 62 61 61 61
Debts 10.699 7.603 614 -661 363 2.026 2.331 2.001 1.210 1.500
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 118.463 euro in 2023 which includes Inventories of 674 euro, Receivables of 116.646 euro and cash availability of 1.143 euro.
The company's Equity was valued at 117.016 euro, while total Liabilities amounted to 1.500 euro. Equity increased by 19.235 euro, from 98.079 euro in 2022, to 117.016 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Stereopsis Clinic Srl

Comments - Stereopsis Clinic Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.